Suchergebnisse - "Li, Jiayi"

PubPharm (919)

91

miR-186-5p targets TGFβR2 to inhibit RAW264.7 cell migration and proliferation during mouse skin wound healing

enthalten in: Environmental toxicology | 2023

von Wang, Y. | Li, Y. | Ni, D. | +16

92

High-Molecular-Weight and Light-Colored Disulfide-Bond-Embedded Polyesters : Accelerated Hydrolysis Triggered by Redox Responsiveness

enthalten in: Biomacromolecules | 2023

von Hu, H. | Luan, Q. | Li, J. | +5

93

Biobased Biodegradable Copolyesters from 2,5-Thiophenedicarboxylic Acid : Effect of Aliphatic Diols on Barrier Properties and Degradation

enthalten in: Biomacromolecules | 2023

von Wang, Q. | Li, J. | Wang, J. | +7

94

Liquid-liquid interfaces enable tunable cell confinement to recapitulate surrounding tissue deformations during neutrophil interstitial migration in vivo

enthalten in: bioRxiv : the preprint server for biology | 2023

von Schrope, J. | Horn, A. | Farooqui, M. | +10

95

Spontaneous mutation in the COL6A2 gene causing Ullrich congenital muscular dystrophy type 1 in a Chinese child : A case report

enthalten in: Medicine | 2023

von Li, J. | Lin, S. | Wu, Q. | +3

96

Terpenoid derivative in elephantopus scaber as well as preparation method and application thereof

enthalten in: Europäisches Patentamt | 2023

von SONG SHAOJIANG | BAI MING | HUANG XIAOXIAO | +1

97

Terpenoid derivative in elephantopus scaber as well as preparation method and application thereof

enthalten in: Europäisches Patentamt | 2023

von SONG SHAOJIANG | BAI MING | HUANG XIAOXIAO | +1

98

Design, synthesis, and biological evaluation of novel 4,4'-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer

enthalten in: European journal of medicinal chemistry | 2023

von Gao, G. | Li, J. | Cao, Y. | +8

99

Discovery of 4-((3,4-dichlorophenyl)amino)-2-methylquinolin-6-ol derivatives as EGFR and HDAC dual inhibitors

enthalten in: European journal of pharmacology | 2023

von Qian, Y. | Zhou, S. | Li, J. | +12

100

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer : The ORIENT-16 Randomized Clinical Trial

enthalten in: JAMA | 2023

von Xu, J. | Jiang, H. | Pan, Y. | +66

CommentIn: JAMA. 2024 Apr 16;331(15):1333-1334. - PMID 38512227